We proposed to exploit hypoxia-inducible factor (HIF)-1alpha overexpression in prostate tumours and use this transcriptional machinery to control the expression of the suicide gene cytosine deaminase (CD) through binding of HIF-1alpha to arrangements of hypoxia response elements. CD is a prodrug activation enzyme, which converts inactive 5-fluorocytosine to active 5-fluorouracil (5-FU), allowing selective killing of vector containing cells.
Laure Marignol, Ruth Foley, Thomas Southgate, Mary Coffey, Donal Hollywood and Mark Lawler
Download Paper
Non-Surgical Solutions for Skin Cancer: The Role of Radiotherapy
Explore the transformative impact of radiotherapy in skin cancer management, focusing on the three Cs: Cure, Cosmesis, and Convenience. This webinar offers dermatologists and GPs practical insights into radiotherapy practices to optimise patient outcomes for...
